UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.19+0.97 (+7.34%)
At close: 4:00PM EDT
14.19 0.00 (0.00%)
After hours: 06:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
123,290
135,082
19,886
13,469
911
Operating expenses
Research development
92,563
107,851
113,820
75,531
48,524
Selling general and administrative
23,776
21,749
17,657
15,238
11,795
Total operating expenses
116,457
129,697
131,565
90,851
60,396
Operating income or loss
6,833
5,385
-111,679
-77,382
-59,485
Total other income/expenses net
1,134
2,334
4,490
2,980
1,156
Income before tax
7,967
7,719
-107,189
-74,402
-58,329
Income tax expense
-387
-691
-816
-389
-204
Income from continuing operations
8,354
8,410
-106,373
-74,013
-58,125
Net income
8,354
8,410
-106,373
-74,013
-58,125
Net income available to common shareholders
8,354
8,410
-106,373
-74,013
-58,125
Basic EPS
-
0.18
-2.49
-2.06
-1.86
Diluted EPS
-
0.18
-2.49
-2.06
-1.86
Basic average shares
-
47,413
42,669
35,893
31,203
Diluted average shares
-
47,915
42,669
35,893
31,203
EBITDA
-
5,594
-111,481
-77,012
-58,990